Dainippon, SanBio Call Time On Stroke Cell Therapy Alliance

SanBio To Press On Despite Trial Failure

 
• By Ian Haydock
  
Broken deal
SanBio Considers Options After End Of Cell Therapy Deal • Source: Shutterstock

More from Strategy

More from Business